Analystreport

Cumberland Pharmaceuticals (NASDAQ: CPIX) is now covered by analysts at B. Riley. They set a "buy" rating and a $9.25 price target on the stock.

Cumberland Pharmaceuticals Inc.  (CPIX) 
Last cumberland pharmaceuticals inc. earnings: 3/18 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: investor.shareholder.com/cpix/index.cfm